J Biol Chem, Vol. 274, Issue 43, 30439-30446, October 22, 1999
A Novel Calcium Signaling Pathway Targets the c-fos
Intragenic Transcriptional Pausing Site*
Vincent
Coulon
§,
Jean-Luc
Veyrune
¶,
Nikolaï
Tourkine,
Annick
Vié,
Robert A.
Hipskind, and
Jean-Marie
Blanchard
From the Institut de Génétique Moléculaire, CNRS,
UMR 5535, IFR24, 1919 route de Mende,
34293 Montpellier cedex 5, France
 |
ABSTRACT |
In many cell types, increased intracellular
calcium gives rise to a robust induction of c-fos gene
expression. Here we show that in mouse Ltk
fibroblasts,
calcium ionophore acts in synergy with either cAMP or PMA to strongly
induce the endogenous c-fos gene. Run-on analysis shows
that this corresponds to a substantial increase in active polymerases
on downstream gene sequences, i.e. relief of an elongation block by calcium. Correspondingly a chimeric gene, in which the human
metallothionein promoter is fused to the fos gene, is
strongly induced by ionophore alone, unlike a c-fos
promoter/
-globin coding unit chimeric construct. Internal deletions
in the hMT-fos reporter localize the intragenic calcium regulatory
element to the 5' portion of intron 1, thereby confirming and extending
previous in vitro mapping data. Ionophore induced cAMP
response element-binding protein phosphorylation on Ser133
without affecting the extracellular signal-regulated kinase cascade. Surprisingly, induction involved neither CaM-Ks nor calcineurin, while
the calmodulin antagonist W7 activated c-fos transcription on its own. These data suggest that a novel calcium signaling pathway
mediates intragenic regulation of c-fos expression via suppression of a transcriptional pause site.
 |
INTRODUCTION |
The proto-oncogene c-fos represents the prototype for
the family of immediate early genes. Its activation follows stimulation of the cell by a wide range of extracellular stimuli but is independent of protein neosynthesis (1-3). c-fos expression is
regulated at multiple levels by intracellular signaling events acting
in synergy (for reviews, see Refs. 4-7). The majority of studies on
how signal transduction cascades modulate c-fos gene
expression have focused on its upstream promoter sequences. Several
cis-acting elements present in this region have been characterized as
targets for numerous stimuli (8-11): the v-sis inducible
element (12, 13), the serum response element
(SRE)1 (7, 14-16), the Fos
AP1-like site (16) and the cAMP response element (CRE)
(17-21).
In several cell types calcium mobilization plays a central role in the
modulation of c-fos gene expression; however, the mechanisms involved are still not fully understood. Calcium ions act as
intracellular secondary messengers either after entering cells through
various ion channels and/or upon release from internal stores.
Ca2+ differentially activates cellular processes, and
immediate early genes such as c-fos gene provide important
targets to characterize how the calcium signal is transduced to the
nucleus to activate various transcription programs (22, 23). Based on
results from mutagenesis and transient transfection analyses, calcium has been proposed to activate a variety of pathways targeting different
promoter elements (8, 21). Some are mediated by SRE-dependent processes. In some instances this occurs via
the well characterized Ras-Raf-Erk-Elk-1 signaling module (23-26). In
other situations increased levels of intracellular calcium induced by
membrane depolarization with elevated levels of KCl or exposure to the
calcium ionophore ionomycin have been shown to activate the
c-fos promoter in PC12 pheochromocytoma cells. These have
been linked to SRF independently of Elk-1 (24). SRF-driven activation
did not involve Ras but did appear to involve
calcium/calmodulin-dependent kinases (25). The mechanism is
still uncertain, since mutation of the major phosphorylation site in
SRF showed continued activity in this study. Finally some evidence
implies that calcium signals to the Fos AP1-like element immediately
downstream of the SRE-binding site (26), even though no transcription
factor has been directly implicated in control via the Fos AP1-like
site alone.
Other pathways activate c-fos transcription independently of
the SRE, primarily via the CRE located at position
65 (reviewed in
Refs. 27 and 28). This element is sufficient to mediate calcium-dependent reporter gene activation in some cell
contexts, while in other cells additional cryptic CREs in the upstream
promoter contribute to reporter gene activity (19). To further
complicate the role of the CRE, intracellular calcium fluxes can also
activate kinases downstream of Ras and ERK that phosphorylate CREB at
serine 133 and thus potentially modulate transcription through the CRE (14, 29).
An explanation for the multiplicity of the effects mediated by calcium
on gene expression has recently been provided by elegant microinjection
experiments aimed at unraveling how spatially distinct calcium signals
generate diverse transcriptional responses (30). Nuclear injection of a
non-diffusible calcium chelator blocked increases in nuclear, but not
cytoplasmic, calcium concentrations following activation of L-type
voltage-gated calcium channels in a mouse pituitary cell line. Using
reporters driven by different c-fos promoter regions,
Hardingham et al. (30) showed that increases in nuclear
calcium control CRE-mediated transcription, whereas a rise of
cytoplasmic calcium activated SRE-driven transcription. In fact, this
suggests that the mode of calcium entry and the cell type determine
which upstream promoter element is required for the activation of a
transiently introduced reporter gene. Accordingly the CRE alone can
mediate activation by calcium signals triggered by membrane
depolarization of PC12 pheochromocytoma cells (21, 22, 31), an effect
that is not reproduced in HeLa cells (8).
More recently, a new calcium-sensitive transcriptional repressor has
been proposed to bind a downstream regulatory element (DRE) present
within the human prodynorphin gene (32). Upon stimulation by calcium
this repressor, named DREAM for DRE-antagonist modulator, is no longer
able to bind the DRE. In addition to prodynorphin promoter, DREAM
represses also transcription from the c-fos gene in a
transient transfection assay. However, whether this is true for the
endogenous gene remains to be established.
A close inspection of the c-fos transcription unit through
high resolution run-on analysis has also suggested the involvement of
intragenic regulatory elements as important targets of c-fos regulation by calcium (33-36). In cultured macrophages,
c-fos transcription is stimulated by multiple pathways
requiring the mobilization of calcium from internal sources (34, 37). A
strong block to transcriptional elongation, mapping beyond
c-fos exon 1, was observed when freshly isolated peritoneal
macrophages were put into primary culture (34).
Calcium-dependent relief of this block strongly increased
c-fos mRNA levels. In T cells, elevated cytoplasmic
calcium is a critical mediator of activation upon stimulation of the
antigen receptor. The synergistic action of calcium ionophore and
agonists of protein kinase C mimics authentic antigen treatment in some
T cell hybridomas (38). In the latter case, the principal effect of
calcium was shown to be on the elongation of c-fos
transcripts (35).
Using nuclear extracts from Ltk
cells, we had previously
mapped an in vitro arrest site within the murine
c-fos gene (39). In this work we confirm and extend these
results in vivo. However, because most previous studies on
c-fos transcription have dealt with transient transfection
experiments, we sought to use permanent cell lines carrying integrated
reporter genes. We find that a sequence within c-fos intron
1, while barely active on its own, can strongly augment a calcium
ionophore-driven transcriptional response together with its homologous
or a heterologous upstream promoter. Even though this is correlated
with CREB phosphorylation on Ser133, it is mediated by a
novel signaling pathway that surprisingly is potentiated by the
calmodulin antagonist W7.
 |
EXPERIMENTAL PROCEDURES |
Materials and Reagents--
Tissue culture medium, penicillin,
streptomycin, glutamine, G418, Random primers DNA labeling system, and
TRIZOL were obtained from Life Technologies, Inc. (Cergy Pontoise,
France). Phorbol myristate acetate (PMA), 3-isobutyl-1-methylxanthine
(IBMX), 8-bromo cyclic adenosine monophosphate (8-Br-cAMP), A23187, W5,
W7, KN62, KN93, and secondary antibodies were purchased from
Sigma-Aldrich (St. Quentin Fallavier, France). Antisera directed
against phosphorylated forms of CREB and ERK came from New England
Biolabs (Ozyme, Paris), all radioactive nucleotides and ECL reagents
were from Amersham Pharmacia Biotech, the pHOOK-2 vector and
Capture-Tec beads came from Invitrogen (Groningen, The Netherlands),
and all restriction enzymes and bovine serum albumin from Roche
Molecular Biochemicals (Meylan, France). The
calmodulin-dependent protein kinase assay kit was purchased
from Upstate Biotechnology Inc. (EUROMEDEX, France). Bradford protein
assay kit was from Bio-Rad (Ivry Sur Seine, France) and Immobilon
polyvinylidene difluoride membranes from Millipore. Radioactive signals
were revealed by autoradiography using intensifying screens at
80 °C and quantitated by PhosphorImager technology.
Cell Culture--
Mouse Ltk
fibroblasts were grown
at 37 °C in a 5% CO2 containing atmosphere in the
presence of 10% fetal calf serum in Dulbecco's modified Eagle's
medium. When indicated, cells were serum starved for 24 h and
stimulated by refeeding with 10% serum for the indicated times.
3-5 × 106 exponentially growing cells were treated
with either 100 nM PMA, 100 mM IBMX + 1 mM 8-Br-cAMP, 0.1-10 µM rapamycin or
cyclosporin A, 10 µM KN62 or KN93, 2.5-250
µM W5 or W7, 20 µM PD98059, or 10 mg/ml of
the calcium ionophore A23187 alone, or a combination of these agents as
indicated in the legends of the figures. All media were supplemented
with streptomycin, penicillin, and L-glutamine. Cells were
transfected with the various constructs described in the figures using
calcium phosphate and pools of G418-resistant cells were used
throughout this work.
pHOOK-2 Transient Transfection and Selection--
6 µg of
pHOOK-2-Lac Z (control), CaM-KIIi-HOOK, CaM-KIIa-HOOK, or CaM-KIVa-HOOK
were transfected in 3-5 × 106 Ltk
p19/1 cells by the calcium phosphate technique. 16 h later, cells were washed with HS buffer (25 mM Hepes, 140 mM
NaCl, pH 7.4), fresh Dulbecco's modified Eagle's medium containing
10% fetal calf serum was added and after 2 h A23187 stimulation
was performed, where indicated, for 1 h. Cells were then detached
with 6 mM EDTA, spun down, and resuspended in 5 ml of
Dulbecco's modified Eagle's medium, 10% fetal calf serum, also
containing A23187 where indicated. 50 µl of magnetics beads
(Invitrogen Capture-Tec system) were added and tubes were gently
stirred at 37 °C for 1 h. After selection on a magnetic stand
and 3 washes with Dulbecco's modified Eagle's medium, 10% fetal calf
serum, the cells were split into two batches: one was resuspended in
TRIZOL reagent for RNA extraction while the other one was treated with
Laemmli's polyacrylamide gel electrophoresis-SDS sample buffer.
Nuclear Run-on Transcription--
Extraction of nuclei, run-on
transcript labeling and hybridization were carried out as described
(39). Preparations of crude nuclei were split into aliquots containing
5 × 107 nuclei which were frozen in liquid nitrogen
and thawed immediately prior to the labeling reaction. Incubations were
carried out at 30 °C for 30 min in the presence of 100 µCi of
[
-32P]UTP (400 Ci/mmol, 10 µCi/µl). Labeled run-on
transcripts were purified and hybridized to nitrocellulose filters
containing equimolar amounts of the plasmids indicated. Hybridization
was carried out for 48 h at 42 °C. Filters were washed twice at
65 °C in 0.2 × SSC and at 25 °C in 2 × SSC containing
2 µg/ml DNase-free RNase A. Signals were corrected for the thymidine
content of each hybridizing DNA strand and standardized to those
obtained with the gapdh cDNA probe.
RNA Blots and RNase Protection Assay--
Total RNA was
extracted using a standard 5 M guanidinium
thiocyanate-phenol procedure at pH 5. Blots were sequentially
hybridized to a mouse c-fos and gapdh cDNA
probes labeled by random priming with [
-32P]dCTP (3000 Ci/mmol). The RNA probe was prepared from PM37.37 (containing a mouse
genomic c-fos DNA spanning nucleotides
599 to +251, cloned
into pBluescript) linearized with BssHII, uniformly labeled
with [
-32P]UTP (400 Ci/mmol), and purified by
polyacrylamide gel electrophoresis. 20 µg of RNA for each sample was
hybridized, processed for degradation by RNase A, and the resulting
protected bands analyzed by electrophoresis in 5% polyacrylamide
sequencing gels as described (40).
Plasmid Constructs--
For c-fos constructs the
starting construct was p19/1, which contains a 4-kilobase
NaeI-BamHI mouse genomic DNA fragment under the
control of the human metallothionein IIa promoter (41). Large deletions
were generated using unique XhoI, XbaI, and
SalI restriction sites and religation as indicated. Intron 1 small deletions were generated with exonuclease III on
XhoI-linearized p19/1, followed by blunt-ending by S1
nuclease treatment and religation. Plasmids containing overlapping
deletions were selected and sequenced. pMT-globin was derived from
p19/1 after deleting the BamHI-BamHI c-fos fragment and replacing it with a rabbit
-globin
genomic fragment. pFos-globin contained the rabbit
-globin gene
under the control of the c-fos promoter contained in the
SmaI-PvuII DNA fragment spanning nucleotides
500 to
19 relative to the transcription initiation site (42).
The CaM kinase II catalytic subunit (amino acids 1-290) was derived
from plasmids pSG5-192 I (inactive) or pSG5-192 A (active) (Ref. 43,
kind gift from A. Means) by HindIII and BamHI
digestion. These fragments were cloned in the pHOOK-2 vector to produce
CaM-KIIi-HOOK and CaM-KIIa-HOOK. The CaM kinase IV catalytic subunit
(amino acids 1-313) was obtained from plasmid RSV-CaM-KIV (Ref. 44, kindly provided by S. Soderling) by HindIII and
BglII digestion and cloned in pHOOK-2 vector to produce
CaM-KIVa-HOOK.
Western Blots and Kinase Assays--
5 × 105
exponentially growing cells were treated with various inhibitors for
1 h prior to A23187 stimulation for 10 min as indicated and then
lysed as described previously (45). Protein concentrations were
determined using the Bradford assay. 5 µg of whole cell extracts were
fractionated by electrophoresis through 8.5% SDS gels and transferred
onto polyvinylidene difluoride membranes. After a quick dip into
methanol, membranes were saturated for 1 h at room temperature in
TBST (10 mM Tris-HCl, pH 8, 150 mM NaCl, 0.05%
Tween 20) containing 5% bovine serum albumin (fraction V). Primary
antibodies (anti-phospho-Thr183/Tyr185 ERK or
anti-phospho-Ser133 CREB) were incubated overnight at
4 °C in the same medium at a 1/1000 dilution. After 3 washes with
TBST, an anti-rabbit IgG antibody was added at a 1/5000 dilution for
1 h at room temperature. Antibody complexes were revealed by
enhanced chemiluminescence (ECL kit) after 6 washes 5 min each with TBST.
CaM-activated kinases were purified through a small scale quick batch
binding of a whole cell extract (100 µg) to a calmodulin affinity
resin (Stratagene). Activity was measured by incubating the immobilized
kinases for 10 min at 30 °C in 50 µl of a mixture containing 100 µM auto Camtide II, 2 µM each of PKC and
PKA inhibitor peptides, 25 mM MgCl2, 100 µM [
-32P]ATP (10 µCi), 20 mM MOPS, pH 7.2, 25 mM
-glycerolphosphate, 1 mM sodium orthovanadate, 1 mM dithiothreitol, 1 mM CaCl2. Incorporated radioactivity was
monitored by liquid scintillation after spotting 25 µl of reaction
mixture onto P81 phosphocellulose paper and several washes with 0.75%
phosphoric acid, according to the supplier's recommendations.
 |
RESULTS |
c-fos Induction in Ltk
Cells Requires the Concerted
Action of Calcium Ionophore and Phorbol Esters or cAMP--
We
initially analyzed the response of mouse Ltk
fibroblasts
to agents that elevate intracellular levels of calcium and/or cAMP,
since these pathways were shown to synergize in c-fos
activation (46, 47). In Ltk
cells, PMA, IBMX + 8-Br-cAMP,
or calcium ionophore (A23187) generated only a minor induction of
c-fos mRNA (Fig.
1A). In contrast, co-treatment with A23187 and either PMA or IBMX + 8-Br-cAMP gave rise to a much
stronger induction of c-fos (Fig. 1A). Notably
the signal was still high after 4 h of stimulation by a
combination of A23187 + IBMX + 8-Br-cAMP, whereas it was undetectable
90 min after serum refeeding (Fig. 1B). This strong
induction was sensitive to actinomycin D (data not shown; Fig. 4),
indicating that it resulted from an increase in de novo
transcription.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 1.
Calcium ionophore is required for robust,
sustained induction of c-fos by PMA or cAMP in
Ltk cells. A, exponentially growing
Ltk cells were left uninduced (lane 1) or
stimulated for 1 (lanes 2-6), 2 (lane 7), or
4 h (lane 8) with PMA (lane 2), IBMX + 8-Br-cAMP (lane 3), A23187 (lane 4), or a
combination of A23187 and PMA (lane 5) or IBMX + 8-Br-cAMP
(lanes 6-8). 20 µg of total RNA was fractionated by
electrophoresis through a formaldehyde-agarose gel, transferred onto
nylon membranes and hybridized successively to c-fos
(top panels) and gapdh (bottom panels)
probes. B, transient expression of c-fos mRNA
induced by serum restimulation of Ltk cells starved for
24 h. Total RNA was prepared from either serum-starved cells
(lane 1) or cells restimulated for 30 (lane 2),
60 (lane 3), or 90 min (lane 4) and analyzed as
above.
|
|
This was confirmed by a run-on analysis carried out on nuclei prepared
from cells treated for 1 h with A23187, 8-Br-cAMP and IBMX (Fig.
2). The labeled nascent transcripts were
hybridized to two DNA fragments spanning the 5'-half of the murine
c-fos gene. The first one, (A), contains the first exon and
the 3'-half of the first intron. The second (B), spans the 3'-half of
the first intron, the second exon and the 5'-half of the second intron. Previous work has shown that c-fos transcription can be
regulated in part at the level of elongation (34, 35, 40, 48, 49), and
fragment A contains the premature termination site mapped in
vitro (39). Prior to stimulation, a signal was detected on the
promoter proximal fragment, whereas that from fragment B was disproportionately low, especially upon correction for the amount of
uridine transcribed into RNA hybridizing to each fragment. Induction
gave rise to a small increase in transcription of fragment A, together
with a strongly enhanced signal from fragment B. Thus, in
Ltk
cells the endogenous c-fos gene is
regulated at the level of transcriptional elongation.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
Ionophore treatment relieves a
transcriptional block within c-fos intron 1. Nuclei were isolated from exponentially growing Ltk cells
stimulated for 1 h with IBMX + 8-Br-cAMP in the absence of A23187
( ) or presence (+). Nascent transcripts were labeled in
vitro with [ -32P]UTP and then hybridized to
c-fos mouse genomic DNA fragments spanning nucleotides +42
to +580 (fragment A) and +580 to +1473 (fragment B) relative to the
transcription start site. c-fos signals were normalized to
gapdh signals after PhosphorImager quantitation and
correction for the uridine content of each transcript. The main
features of c-fos transcription unit are diagrammed:
shaded rectangles represent exons, black bars
correspond to intron or flanking sequences, the transcription
initiation site is represented by a broken arrow, and the
horizontal arrows below the gene show the
NaeI-XhoI (fragment A) and
XhoI-XbaI (fragment B) DNA fragments used for the
run-on transcript hybridization. Left panels, autoradiograms
of membranes hybridized to in vitro synthesized nuclear RNA
from either untreated cells ( ) or cells exposed to A23187 + IBMX + 8-Br-cAMP for 1 h (+). pUC and gapdh refer to pUC18 and
rat gapdh cDNAs. Right panel, the
hybridization signals on fragments A and B are represented relative to
the signal on A, after normalization for their specific activity and
the corresponding gapdh signal.
|
|
Interestingly, A23187 also acts to stabilize c-fos mRNA.
Cells were stimulated for 1 h with A23187 + IBMX + 8-Br-cAMP, and then actinomycin D was added for the indicated times (Fig.
3A). c-fos mRNA
was still detectable 4 h after actinomycin D addition, whereas the
same level was obtained with a 1-h actinomycin D chase after serum
induction (Fig. 3B). The synergy between calcium ionophore and the other inducers suggests that both upstream and downstream regulatory elements are required for a full response to calcium in
these cells.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Calcium ionophore leads to c-fos mRNA stabilization. A, Northern blot analysis
of c-fos mRNA decay after treatment with A23187 + IBMX + cAMP for 1 h prior to addition of actinomycin D for the indicated
times. RNA was processed as described in the legend of Fig. 1.
B, quantitation of the data presented in panel A
after normalization to the gapdh signals (closed
bars). Also shown is the decay rate of c-fos mRNA
following a 30-min serum induction (open bars).
|
|
A c-fos Gene under the Control of an Heterologous Promoter Shows a
Full Response to Calcium Ionophore--
To address the contribution of
regions downstream from the promoter to the calcium effect, we
transfected Ltk
cells with a construct expressing the
mouse c-fos gene under the control of the human
metallothionein IIa promoter (MTLIIa) (p19/1; Ref. 41), which has high
basal activity. A23187 alone was sufficient to substantially induce
(60-fold) the transfected gene (Fig.
4A), unlike the endogenous
c-fos gene (see above). A slightly reduced induction
(30-fold) was observed with a mutant lacking the 3'-untranslated region
(p19/
NsiI-MstII) that was previously shown to enhance mRNA
stability (49-52). This is consistent with the increase in stability
observed above for the endogenous gene. Actinomycin D blocked the
induction but had a less striking effect on basal transcription (Fig.
4A). This observation was confirmed by RNase protection
using an antisense probe spanning from nucleotides
95 to +251
relative to the transcription start site (Fig.
5A). The c-fos
mRNA generated by the transfected gene lacks the first 42 nucleotides and can thus easily be distinguished from the endogenous
mRNA (see "Experimental Procedures"). As shown in Fig.
5B, the transfected gene was induced to the same level by calcium ionophore alone or together with IBMX + 8-Br-cAMP
(lanes 6 and 7) or PMA (not shown), whereas the
endogenous c-fos mRNA was observed only after combined
treatment (lanes 4 and 7). The RNA samples used
in this experiment are those used for the Northern blot of Fig. 1.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 4.
c-fos intragenic sequences
confer calcium inducibility to a heterologous promoter.
A, exponentially growing Ltk cells, stably
transfected with p19/1 (lanes 1-3) or p19/1 NsiI-MstII
(lanes 4-6), were stimulated for 1 h with A23187,
followed by actinomycin D as indicated. B, exponentially
growing Ltk cells, stably transfected with either
pMT-globin (lanes 1 and 2) or pFos-globin
(lanes 3 and 4), were induced for 1 h with
A23187 as indicated. RNA from cells left untreated ( ) or treated as
indicated (+) was processed for Northern blot analysis as described in
the legend of Fig. 1. A mouse c-fos cDNA probe was used
in A and a rabbit genomic DNA probe was used in
B. In all cases membranes were rehybridized to a rat
gapdh probe for normalization. The band marked by an
asterisk in the upper panels of panel B,
lanes 3 and 4, represent a globin splicing intermediate
(53).
|
|

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 5.
RNase protection analysis of induction of the
endogenous c-fos and exogenous MTLIIa-fos genes. A, schematic representation of the 5'
portion of the endogenous c-fos gene as well as the chimeric
gene encoded by p19/1. Shaded rectangles represent exons and
black horizontal bars introns or flanking sequences. The
open rectangle indicates the MTLIIa promoter in the chimeric
construct. The horizontal arrow and the lines
below positions the antisense RNA probe and indicates the expected
protection products. These are bands of 251 and 209 nucleotides that
correspond to transcripts generated from the endogenous gene and the
transgenic construct, respectively. B, exponentially growing
Ltk cells (lanes 1-4), or Ltk
cells stably transfected with p19/1 (lanes 5-7), were
stimulated for 1 h with A23187 alone (lane 3 and
6) or together with 8-Br-cAMP (lanes 4 and
7) as indicated. 20 µg of RNA from uninduced ( ) or
induced (+) cells was hybridized and processed for RNase protection.
Lane 1 shows the result using RNA from serum restimulated
cells. The results shown are representative of three independent
experiments. The faster migrating band of lane 7 is an
artifact not observed in other analyses.
|
|
This effect was related to the fos gene, since no modulation
by calcium was seen when a rabbit
-globin genomic sequence was placed downstream from the MTLIIa promoter (Fig. 4B, lanes 1 and 2). Nevertheless the same construct was inducible by
Zn2+ (data not shown). When the same
-globin genomic
sequence was appended 3' to the c-fos promoter (
400 to
+10), the resulting globin mRNA was only modestly induced by
calcium (at most 3-fold, Fig. 4B, lanes 3 and 4),
in contrast to the strong induction of the complete c-fos
gene (Fig. 4A). The c-fos promoter- globin coding
construct was still inducible by serum (data not shown; Ref. 53). Since
similar results were observed with other promoters linked to the
c-fos gene (adenovirus MLP, rat
-actin; data not shown),
we conclude that sequences located within the c-fos gene are
required for a full transcriptional response to calcium.
The Intragenic Calcium Response Requires Sequences Located within
c-fos Exon 1 and Intron 1--
We then employed deletion mutagenesis
to characterize the portion of the gene responsible for calcium
sensitivity. A first series of deletions was generated using several
restriction sites scattered along the transcription unit, as diagrammed
in Fig. 6A. Plasmids
corresponding to the various minigenes were transfected into
Ltk
cells, and pools of neomycin-resistant cells were
used for monitoring A23187 inducibility. Deletions spanning sequences
downstream of the middle of intron 1 were induced to approximately the
same level as the starting p19/1 construct (35-55-fold,
XS and
XX, Fig. 6).
NX, which removes exon 1 and the 5' portion of
intron 1, was only poorly induced (2-3-fold) and exhibited a high
constitutive level of expression prior to stimulation. The region
deleted in
NX contains a previously mapped in vitro
arrest site (39), as well as an in vivo pause site (40).
This suggests thus that calcium acts at the level of elongation rather
than initiation. Consistent with this, c-fos mRNA
induction by calcium ionophore in p19/1 stably transfected
Ltk
cells was completely abolished by preincubation with
the elongation inhibitor DRB (data not shown).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
Sequences contained within exon 1 and/or
intron 1 of c-fos are required for a robust response
to calcium. A, the upper panel diagrams the
deletions introduced into the chimeric c-fos gene encoded by
p19/1. The symbols are described in the legend to Fig. 5,
and the bars under the gene represent the various deletions.
Exponentially growing Ltk cells stably transfected with
the three deletion mutants were left uninduced ( ) or induced for
1 h with A23187 (+). Induction was analyzed by Northern blotting
as described in the legend to Fig. 1. B, quantitative
representation of induction. The hybridization signals in Panel
A were analyzed densitometrically and normalized to the
gapdh signal.
|
|
In order to confirm the involvement of the transcriptional pause site
in this effect, we generated a new series of deletions restricted to
intron 1 (Fig. 7C). Stably
transfected pools of Ltk
cells were established as above
and used for in vitro run-on experiments (Fig.
7A). Dot blot hybridizations were performed on DNA from each
pool of cells in order to ensure that the copy number of each
transfected construct (which ranged from 20 to 30) was high enough to
render insignificant the signal arising from the endogenous gene. This
was confirmed by run-on analysis (data not shown). Although not as
pronounced as for the endogenous gene (Fig. 2), the transgene still
harbored a block to transcriptional elongation at the level of basal
transcription (Fig. 7). Mutant
1 showed the same biased
hybridization signal to fragment A observed with the wild type gene
(Fig. 7, A and B), which is indicative of a
transcriptional pause (see above). Notably the signal became less
biased upon further deletion (compare white bars (fragment A) and black bars (fragment B) in Fig. 7B),
suggesting the gradual alleviation of transcriptional pausing. This
confirms the key role played by intron 1 sequences in c-fos
regulation in Ltk
cells.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 7.
The transcriptional pause site targeted by
calcium ionophore maps in the 5' part of c-fos intron
1. A, nuclei were prepared from exponentially growing
Ltk cells stably transfected with the various deletion
mutants of p19/1. Run-ons were performed as indicated in Fig. 2 and
nascent transcripts were hybridized to the c-fos NaeI-XhoI (fragment A) and
XhoI-XbaI (fragment B) probes as well as to
gapdh as described in the legend to Fig. 2. Experiments have
been carried out three times and only a representative example is shown
here. B, ratios of the signals detected on fragments A and
B. The hybridization signals in panel A were quantitated and
normalized to gapdh (open bars). The theoretical
ratio, based on uridine content of transcripts arising from each
deletion mutant, is presented as the solid bars.
C, schematic representation of the deletions introduced into
intron 1 of p19/1. The symbols are described in the legend
to Fig. 6. The horizontal lines below portray the
overlapping deletions centered on the XhoI site.
Numbers refer to positions relative to the transcription
initiation site. The white box present in intron 1 between
positions +363 and +387 shows the previously mapped in vitro
transcriptional pause site (39).
|
|
c-fos Induction by Calcium in Ltk
Cells Does Not
Involve Calmodulin-activated Kinases II and IV or Calcineurin--
A
major mechanism by which an increase in intracellular calcium
concentration regulates cellular events is through its association with
calmodulin (CaM). The calcium-CaM complex binds to and modulates the
activity of multiple regulatory molecules, including the CaM-activated kinase family (CaM-K) (54). CaM-Ks appear to play a role in transcriptional activation because the calcium-dependent
induction of several immediate early genes, such as c-fos,
is blocked by the CaM-K inhibitors KN62 and KN93 (26, 55). This has
been proposed to occur through CREB phosphorylation (44, 56, 57), SRF
phosphorylation (28), and via an interaction between the CaM-K cascade
and mitogen-activated protein kinase signaling pathways (58). We
therefore investigated these possibilities in our experimental system.
Consistent with previous studies (59), treatment of p19/1 cells with
calcium ionophore led to increased CREB phosphorylation, as measured by
Western blotting and immunodetection with anti-phospho-CREB antibodies
(data not shown). In contrast, A23187 did not affect the level of
activated ERK1 and ERK2, as monitored on the same blot with
antiphospho-ERK antibodies (not shown). Thus ionophore does not induce
the ERK cascade in Ltk
cells. Ionophore addition did
stimulate CaM-K activity, as demonstrated with a pull-down kinase assay
using calmodulin-affinity resin (Fig.
8A). A 1-h treatment of cells
with KN93 not only abolished ionophore-mediated increase in CaM-K
activity, but led also to a 70% decrease in basal activity (Fig.
8A). However, this did not inhibit c-fos mRNA
induction in p19/1 cells (Fig. 8B).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 8.
CaM Kinase inhibitors do not affect
c-fos mRNA induction by calcium ionophore.
A, cells were pretreated with the CaM-K inhibitor KN93 (10 µM, 10 min) and then stimulated with A23187 as indicated.
Whole cell lysates were prepared and passed over a calmodulin affinity
resin. The immobilized proteins were tested for kinase activity toward
CaMtide, a CaM-K substrate peptide. Reactions were spotted on
phosphocellulose paper, washed exhaustively, and the radioactivity
measured by scintillation counting. B, cells were
preincubated for 1 h with 10 µM KN93, then induced
as indicated above the lanes. Total RNA extraction, Northern blotting,
and hybridization were perfomed as described in the legend to Fig.
1.
|
|
This was somewhat surprising in light of previously published reports.
To confirm the lack of CaM-K effect on c-fos, we transfected p19/1 cells with pHook-based vectors expressing constitutively active
CaM-KII and CaM-KIV kinases. Transfected cells were enriched by
immunoselection, and RNA and proteins processed for Northern and
Western blot analysis. Consistent with the results above, neither
CaM-KII nor CaM-KIV were able to recapitulate c-fos
induction by calcium ionophore (Fig.
9A). In contrast, they were
both able to increase phosphorylation of endogenous CREB (Fig.
9B). Furthermore, overexpression of inactive CaM-KII, which
should compromise activation driven by CaM-KII, did not block
c-fos induction by calcium ionophore (Fig. 9A)
but did prevent A23187-induced CREB phosphorylation (Fig.
9B).

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 9.
Constitutively active CaM-Ks lead to CREB
phosphorylation but fail to induce c-fos expression. Exponentially growing Ltk cells
were transfected with either the parental vector (pHOOK-2-LacZ:
lanes A1, A2, and B1) or expression vectors
encoding constitutively active CaM-KII (CaM-KIIa-HOOK: lanes
A3 and B2), constitutively active CaM-KIV
(CaM-KIVa-HOOK: lanes A4 and B3), or inactive,
dominant negative CaM-KII (CaM-KIIi-HOOK: lanes A5 and
B4). Transfected cells were selected on magnetic beads and
lysed either with TRIZOL for Northern blot analysis (panel
A) or with SDS-polyacrylamide gel electrophoresis sample buffer
for anti-phosphoCREB Western blotting (panel B, the membrane
was stained with Ponceau Red to ensure identical loading). The
lower panel presents the quantitation of the
c-fos hybridization signals normalized to
gapdh.
|
|
The calcium-CaM complex binds also to calcineurin, a
calcium-dependent protein phosphatase implicated in gene
regulation (38, 60). The immunosuppressant cyclosporin A is a potent
calcineurin antagonist, whereas rapamycin, another immunosuppressant,
acts independently of the phosphatase (60). We therefore checked whether cyclosporin A might influence A23187-mediated c-fos
induction. Neither immunosuppressant had a notable effect on a wide
range of concentrations (Fig. 10),
therefore ruling out calcineurin in the effects we observe.

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 10.
Calcineurin does not contribute to calcium
regulation of the c-fos intragenic pausing site.
Exponentially growing Ltk p19/1 cells were pretreated
with various concentrations of either cyclosporin A or rapamycin
for 1 h (+) and then induced where indicated (+) with A23187. Only
results obtained with 1 µM of either drug are shown here.
RNA isolation, Northern blotting, and hybridization were performed as
described in the legend to Fig. 1. The lower panel shows the
ratio of the c-fos signal to gapdh after
PhosphorImager quantitation of the Northern blot.
|
|
Calcium-mediated c-fos Induction Can be Mimicked by the Functional
Inactivation of CaM--
These data eliminated ERKs, CaM-Ks, and
calcineurin as effectors of ionophore induction of c-fos. In
order to evaluate the possible involvement of CaM in another pathway,
we treated the cells with the anti-CaM drug W7 that has been
extensively used to inhibit CaM in culture cell systems. As a control,
we used W5, a drug chemically very similar to W7 but with a much lower affinity for CaM. To our surprise, exposure of cells to W7 prior to
A23187 strongly induced c-fos either with or without A23187, while the control compound W5 was inactive (Fig.
11). This suggests that a novel calcium
dependent pathway, antagonized by CaM, is involved in controlling
transcriptional pausing in the murine c-fos locus.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 11.
A calmodulin antagonist disrupts regulation
of the c-fos intragenic pausing site.
Exponentially growing Ltk p19/1 cells were preincubated
for 1 h with various concentrations of W5 or W7, followed by
induction with A23187. Only results obtained with 25 µM
of either drug are shown here. RNA isolation, Northern blotting, and
hybridization were performed as described in the legend to Fig. 1. The
lower panel presents the quantitation of the
c-fos hybridization signals normalized to
gapdh.
|
|
 |
DISCUSSION |
In this work, based on integrated c-fos reporter genes
and not on transient transfection experiments, we show that calcium acts synergistically with other stimuli to activate c-fos
transcription through both upstream and downstream regulatory elements.
Whereas PMA, IBMX + cAMP, and A23187 alone were not sufficient to give rise to a significant activation of c-fos, any combination
of A23187 with the different inducers led to a strong induction of transcription. Notably upstream c-fos promoter sequences
were not sufficient to confer a high level of inducibility by calcium to a reporter
-globin gene. Conversely, replacing the
c-fos upstream promoter with that from the human
metallothionein IIa promoter generated a chimeric gene highly inducible
by calcium ionophore alone. Nuclear run-on analysis showed that
mRNA accumulation was mainly due to a dramatic increase in
polymerase processivity. These data suggest that intragenic regulatory
elements mediate calcium effects provided that transcription initiation
has taken place.
The pathway leading from calcium entry to transcription resumption was
then evaluated: whereas CaM-Ks activate c-fos gene transcription through promoter proximal elements, astonishingly, their
participation, as well as that of the calcium-dependent phosphatase calcineurin, was ruled out in the relief of the block to
elongation. However, calmodulin is actually implicated in this phenomenon through a mechanism that remains to be characterized. Taken
together, these arguments form a compelling body of data pointing to a
new calcium/calmodulin-dependent pathway that targets intragenic sequences to allow transcription to proceed through the
pause site.
We show here that the metallothionein promoter drives barely detectable
transcription through c-fos downstream sequences. The
striking induction of transcription upon A23187 treatment therefore
reflects a tremendous increase in transcription elongation efficiency.
Importantly the same result was obtained with other constitutively
active promoters, such as the adenovirus major late or rat
-actin
promoters (data not shown). This is consistent with run-on experiments
carried out on cells stably transfected with mutants deleting intron
sequences of c-fos, which further stressed the important
role played by the intragenic transcriptional pause site previously
identified in vivo (40, 48, 61) and mapped in
vitro (39). Thus, in living cells, the first exon plus the 5' part
of the first intron were shown to be crucial for the elongation block,
whose release is responsible for calcium induction of the p19/1 construct.
These results confirm and extend the previous observation by Collart
et al. (34) in macrophages and by Lee and Gilman (35) in
murine T cells. In particular, we show that this calcium-sensitive block to elongation in the 5' part of the c-fos locus can
act independently of the promoter but requires the whole coding unit structure to be fully active. Moreover, this phenomenon is no longer
restricted to macrophages and T-cells but also applies in fibroblasts,
suggesting that it reflects a mechanism with wider relevance than
previously appreciated.
Interestingly, transcriptional induction was amplified by stabilization
of c-fos mRNA when the endogenous gene was activated by
a combination of A23187 and PMA or cAMP. c-fos transcripts generated by the various p19/1-derived constructs after stimulation by
A23187 alone were stabilized to the same extent (data not shown), suggesting that calcium also modulates c-fos mRNA decay
directed by sequences in the 3'-untranslated region. This region cannot function alone, as shown by the inactive deletion mutants where it was
still present. Furthermore, the fact that no deletion mutant retained
full calcium-induced activity is consistent with data from transgenic
mice showing that full c-fos inducibility in vivo requires the entire locus (62).
We then questioned which pathway led to elongation block release in
response to calcium ionophore. Increased intracellular calcium can lead
to activation of PKA and PKC, two important effectors of
c-fos activation in culture cells and in vivo.
The fact that ionophore could synergize with forskolin and PMA, strong
activators of PKA and PKC, makes it unlikely that these two kinases
mediate the effects we observe. Thus CaM-dependent kinases
seemed the most likely candidates, since they have been implicated in
mediating c-fos induction by several different signals and
mechanisms (25, 26, 55, 63, 64). Surprisingly, the CaM-K inhibitor KN93 (nor KN-62: data not shown) did not affect fos induction
although it inhibited both basal and calcium-induced CaM-K activity.
Similarly overexpression of dominant-negative CaM-K did not block
ionophore-driven p19/1 expression, which was also not reproduced by
transfection of constitutively active CaM-Ks II or IV. In contrast, the
latter did lead to CREB phosphorylation. This renders any role for
CaM-Ks in this process very unlikely and suggests that their previously described activation of c-fos transcription takes place at
the level of initiation rather than elongation.
The calcium-activated phosphatase calcineurin regulates gene expression
by activating the nuclear localization of the cytoplasmic transcription
factor NF-ATc (38, 60). This may account for certain signaling events
attributed to cytoplasmic but not nuclear calcium fluxes (30).
Nevertheless calcineurin does not mediate increased elongation driven
by A23187, since the latter was insensitive to the calcineurin
inhibitor cyclosporin A (65).
Recently, DREAM, a new repressor acting through a
location-dependent silencer (DRE) has been shown to lead to
a calcium-dependent repression of a human c-fos
reporter in transient transfection experiments (32). The same sequence
is present in the mouse locus but is not present in our reporter
constructs that show calcium-dependent regulation.
Therefore, the phenomenon we describe here is distinct from
DREAM-dependent repression.
These experiments ruled out a number of well documented pathways
activated by calcium. We thus tested whether the ionophore signal
involved calmodulin itself, using the calmodulin antagonist W7. This
compound led to a dramatic induction of the c-fos p19/1 transgene both with and without A23187. Thus this calmodulin antagonist acts in the same direction as calcium entry, which seems paradoxical at
first sight. One possible explanation is that this reflects a calcium-
and antagonist-sensitive interaction between calcium-free calmodulin
and a factor responsible for the block to elongation. This mechanism
might resemble that described previously for neuromodulin (66, 67), a
neurospecific protein whose function is believed to be to bind
calcium-free calmodulin and concentrate it within specific regions of
the neuron.
The nature of this downstream element and its regulation by calcium
remain to be characterized. It might represent a downstream component
of the promoter, inactive on its own, that interacts with a bona
fide transcription factor. For example, some bHLH proteins have
been shown to interact directly with and be regulated by
calcium/calmodulin in their ability to bind DNA. Accordingly, calcium
ionophore was shown to selectively inhibit transcriptional activation
by these CaM-sensitive bHLH protein in vivo (68). Alternatively this phenomenon might reflect a constrained chromatin structure responsive to calcium. This would explain why this effect has
proven refractory to analysis by transient transfection. Given the
quick response to calcium, one can imagine a direct interaction between
calmodulin and an elongation factor, such as TFIIS, P-TEFb (cycT/cdk9),
or elongin A, a chromatin remodeling system, e.g. Swi/Snf
complex, or a histone acetyltransferase. Although the exact molecular
mechanisms remain unclear, our data add a new, calcium-dependent pathway and promoter region to the
complex signaling network that ensures the tight regulation of
c-fos transcription.
 |
ACKNOWLEDGEMENTS |
We thank A. Means and S. Soderling for
CaM-KII and -IV expression plasmids.
 |
FOOTNOTES |
*
This work was supported in part by grants from the CNRS,
BIOMED2 program, Association pour la Recherche contre le Cancer (ARC), and the Ligue Nationale contre le Cancer (to J. M. B.) and
the Fondation pour la Recherche Medicale and ARC (to R. A. H.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Contributed equally to the results of this work.
§
Supported by a grant from the French Ministry for Education and Research.
¶
Supported by a contract from the BIOMED2 program.
To whom correspondence should be addressed. Tel.:
33-4-67-61-36-49; Fax: 33-4-67-04-02-31; E-mail:
blanchard@igm.cnrs-mop.fr.
 |
ABBREVIATIONS |
The abbreviations used are:
SRE, serum response
element;
CRE, cAMP response element;
CREB, cAMP response
element-binding protein;
DRE, downstream regulatory element;
IBMX, isobutylmethylxanthine;
PMA, phorbol 12-myristate 13-acetate;
8-Br-cAMP, 8-bromo-cAMP;
ERK, extracellular signal-regulated
kinase;
CaM, calmodulin;
CaM-K, CaM-activated kinase family;
SRF, serum
response factor;
MOPS, 4-morpholinepropanesulfonic acid;
MTLIIa, human
metallothionein IIa promoter;
gapdh, glyceraldehyde-3-phosphate dehydrogenase.
 |
REFERENCES |
| 1.
|
Almendral, J. M.,
Sommer, D.,
Macdonald-Bravo, H.,
Burckhardt, J.,
Perera, J.,
and Bravo, R.
(1988)
Mol. Cell. Biol.
8,
2140-2148[Abstract/Free Full Text]
|
| 2.
|
Bravo, R.
(1990)
Semin. Cancer Biol.
1,
37-46[Medline]
[Order article via Infotrieve]
|
| 3.
|
Lau, L. F.,
and Nathans, D.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1182-1186[Abstract/Free Full Text]
|
| 4.
|
Cahill, M. A.,
Janknecht, R.,
and Nordheim, A.
(1996)
Curr. Biol.
6,
16-19[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Janknecht, R.
(1995)
Immunobiology
193,
137-142[Medline]
[Order article via Infotrieve]
|
| 6.
|
Piechaczyk, M.,
and Blanchard, J. M.
(1994)
Crit. Rev. Oncol. Hematol.
17,
93-131[Medline]
[Order article via Infotrieve]
|
| 7.
|
Treisman, R.
(1995)
EMBO J.
14,
4905-4913[Medline]
[Order article via Infotrieve]
|
| 8.
|
Fisch, T. M.,
Prywes, R.,
and Roeder, R. G.
(1987)
Mol. Cell. Biol.
7,
3490-3502[Abstract/Free Full Text]
|
| 9.
|
Gilman, M. Z.,
Wilson, R. N.,
and Weinberg, R. A.
(1986)
Mol. Cell. Biol.
6,
4305-4316[Abstract/Free Full Text]
|
| 10.
|
Lucibello, F. C.,
Ehlert, F.,
and Muller, R.
(1991)
Nucleic Acids Res.
19,
3583-3591[Abstract/Free Full Text]
|
| 11.
|
Visvader, J.,
Sassone-Corsi, P.,
and Verma, I. M.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
9474-9478[Abstract/Free Full Text]
|
| 12.
|
Hayes, T. E.,
Kitchen, A. M.,
and Cochran, B. H.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
1272-1276[Abstract/Free Full Text]
|
| 13.
|
Wagner, B. J.,
Hayes, T. E.,
Hoban, C. J.,
and Cochran, B. H.
(1990)
EMBO J.
9,
4477-4484[Medline]
[Order article via Infotrieve]
|
| 14.
|
Ginty, D. D.,
Bonni, A.,
and Greenberg, M. E.
(1994)
Cell
77,
713-725[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Greenberg, M. E.,
Siegfried, Z.,
and Ziff, E. B.
(1987)
Mol. Cell. Biol.
7,
1217-1225[Abstract/Free Full Text]
|
| 16.
|
Velcich, A.,
and Ziff, E. B.
(1990)
Mol. Cell. Biol.
10,
6273-6282[Abstract/Free Full Text]
|
| 17.
|
Berkowitz, L. A.,
Riabowol, K. T.,
and Gilman, M. Z.
(1989)
Mol. Cell. Biol.
9,
4272-4281[Abstract/Free Full Text]
|
| 18.
|
Fisch, T. M.,
Prywes, R.,
and Roeder, R. G.
(1989)
Mol. Cell. Biol.
9,
1327-1331[Abstract/Free Full Text]
|
| 19.
|
Fisch, T. M.,
Prywes, R.,
Simon, M. C.,
and Roeder, R. G.
(1989)
Genes Dev.
3,
198-211[Abstract/Free Full Text]
|
| 20.
|
Sassone-Corsi, P.,
Visvader, J.,
Ferland, L.,
Mellon, P. L.,
and Verma, I. M.
(1988)
Genes Dev.
2,
1529-1538[Abstract/Free Full Text]
|
| 21.
|
Sheng, M.,
Dougan, S. T.,
McFadden, G.,
and Greenberg, M. E.
(1988)
Mol. Cell. Biol.
8,
2787-2796[Abstract/Free Full Text]
|
| 22.
|
Sheng, M.,
and Greenberg, M. E.
(1990)
Neuron
4,
477-485[Medline]
[Order article via Infotrieve]
|
| 23.
|
Bading, H.,
Ginty, D. D.,
and Greenberg, M. E.
(1993)
Science
260,
181-186[Abstract/Free Full Text]
|
| 24.
|
Hipskind, R. A.,
Rao, V. N.,
Mueller, C. G.,
Reddy, E. S.,
and Nordheim, A.
(1991)
Nature
354,
531-534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Miranti, C. K.,
Ginty, D. D.,
Huang, G.,
Chatila, T.,
and Greenberg, M. E.
(1995)
Mol. Cell. Biol.
15,
3672-3684[Abstract]
|
| 26.
|
Wang, Y.,
and Simonson, M. S.
(1996)
Mol. Cell. Biol.
16,
5915-5923[Abstract]
|
| 27.
|
Greenberg, M. E.,
Thompson, M. A.,
and Sheng, M.
(1992)
J. Physiol. (Paris)
86,
99-108[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Ginty, D. D.
(1997)
Neuron
18,
183-186[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Xing, J.,
Ginty, D. D.,
and Greenberg, M. E.
(1996)
Science
273,
959-963[Abstract]
|
| 30.
|
Hardingham, G. E.,
Chawla, S.,
Johnson, C. M.,
and Bading, H.
(1997)
Nature
385,
260-265[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Sheng, M.,
McFadden, G.,
and Greenberg, M. E.
(1990)
Neuron
4,
571-582[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Carrion, A. M.,
Link, W. A.,
Ledo, F.,
Mellstrom, B.,
and Naranjo, J. R.
(1999)
Nature
398,
80-84[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Thompson, M. A.,
Ginty, D. D.,
Bonni, A.,
and Greenberg, M. E.
(1995)
J. Biol. Chem.
270,
4224-4235[Abstract/Free Full Text]
|
| 34.
|
Collart, M. A.,
Tourkine, N.,
Belin, D.,
Vassalli, P.,
Jeanteur, P.,
and Blanchard, J. M.
(1991)
Mol. Cell. Biol.
11,
2826-2831[Abstract/Free Full Text]
|
| 35.
|
Lee, G.,
and Gilman, M.
(1994)
Mol. Cell. Biol.
14,
4579-4587[Abstract/Free Full Text]
|
| 36.
|
Werlen, G.,
Belin, D.,
Conne, B.,
Roche, E.,
Lew, D. P.,
and Prentki, M.
(1993)
J. Biol. Chem.
268,
16596-16601[Abstract/Free Full Text]
|
| 37.
|
Collart, M. A.,
Belin, D.,
Briottet, C.,
Thorens, B.,
Vassalli, J. D.,
and Vassalli, P.
(1989)
Oncogene
4,
237-241[Medline]
[Order article via Infotrieve]
|
| 38.
|
Crabtree, G. R.,
and Clipstone, N. A.
(1994)
Annu. Rev. Biochem.
63,
1045-1083[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Mechti, N.,
Piechaczyk, M.,
Blanchard, J. M.,
Jeanteur, P.,
and Lebleu, B.
(1991)
Mol. Cell. Biol.
11,
2832-2841[Abstract/Free Full Text]
|
| 40.
|
Plet, A.,
Eick, D.,
and Blanchard, J. M.
(1995)
Oncogene
10,
319-328[Medline]
[Order article via Infotrieve]
|
| 41.
|
Ruther, U.,
Wagner, E. F.,
and Muller, R.
(1985)
EMBO J.
4,
1775-1781[Medline]
[Order article via Infotrieve]
|
| 42.
|
Rech, J.,
and Fort, P.
(1989)
Nucleic Acids Res.
17,
2874[Free Full Text]
|
| 43.
|
Cruzalegui, F. H.,
Kapiloff, M. S.,
Morfin, J. P.,
Kemp, B. E.,
Rosenfeld, M. G.,
and Means, A. R.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
12127-12131[Abstract/Free Full Text]
|
| 44.
|
Sun, P.,
Enslen, H.,
Myung, P. S.,
and Maurer, R. A.
(1994)
Genes Dev.
8,
2527-2539[Abstract/Free Full Text]
|
| 45.
|
Hipskind, R. A.,
Baccarini, M.,
and Nordheim, A.
(1994)
Mol. Cell. Biol.
14,
6219-6231[Abstract/Free Full Text]
|
| 46.
|
Li, S. L.,
Godson, C.,
Roche, E.,
Zhao, S. J.,
Prentki, M.,
and Schlegel, W.
(1994)
J. Mol. Endocrinol.
13,
303-312[Abstract/Free Full Text]
|
| 47.
|
Ran, W.,
Dean, M.,
Levine, R. A.,
Henkle, C.,
and Campisi, J.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
8216-8220[Abstract/Free Full Text]
|
| 48.
|
Sobczak, J.,
Mechti, N.,
Tournier, M. F.,
Blanchard, J. M.,
and Duguet, M.
(1989)
Oncogene
4,
1503-1508[Medline]
[Order article via Infotrieve]
|
| 49.
|
Fort, P.,
Rech, J.,
Vie, A.,
Piechaczyk, M.,
Bonnieu, A.,
Jeanteur, P.,
and Blanchard, J. M.
(1987)
Nucleic Acids Res.
15,
5657-5667[Abstract/Free Full Text]
|
| 50.
|
Rahmsdorf, H. J.,
Schonthal, A.,
Angel, P.,
Litfin, M.,
Ruther, U.,
and Herrlich, P.
(1987)
Nucleic Acids Res.
15,
1643-1659[Abstract/Free Full Text]
|
| 51.
|
Shyu, A. B.,
Greenberg, M. E.,
and Belasco, J. G.
(1989)
Genes Dev.
3,
60-72[Abstract/Free Full Text]
|
| 52.
|
Chen, C. Y.,
Chen, T. M.,
and Shyu, A. B.
(1994)
Mol. Cell. Biol |